Performance of CHROMAGAR candida and BIGGY agar for identification of yeast species

Annals of Clinical Microbiology and Antimicrobials

Volumn 2, Issue , 2003, Pages

  Yücesoy, Mine ^a   Marol, Serhat ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; BISMUTH SALT; GLUCOSE; GLYCINE; SULFITE;

ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KEFYR; CANDIDA KRUSEI; CANDIDA LUSITANIAE; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CELL STRUCTURE; CONTROLLED STUDY; FUNGAL STRAIN; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; NONHUMAN; RELIABILITY; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY; SPECIES DIFFERENTIATION; STRAIN IDENTIFICATION; TRICHOSPORON;

EID: 3042565191     PISSN: 14760711     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-0711-2-8     Document Type: Article

References (28)

1. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G and Dunagan WC: Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992, 15:415-421.
2. Moran GP, Sullivan DJ and Coleman DC: Emergence of non-Candida albicans species as pathogens. In Candida and Candidiasis 1st edition. Edited by: Calderone RA. Washington D.C.: American Society for Microbiology; 2003:37-53.
3. Jarwis WR: Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995, 20:1526-1530.
4. Abi-Said D, Anaissie E, Uzun O, Raad F, Pinzcowski H and Vartivarian S: The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997, 24:1122-1128.
5. Rex JH, Pfaller MA, Barry AL, Nelson PW and C.D. Webb or the NIAID Mycoses Study Group and the Candidemia Study Group: Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B for the treatment of nonneutropenic patients with candidemia. Antimicrob Agents Chemother 1995, 39:40-44.
6. Wingard JR: Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 1995, 20:115-125.
7. Pfaller MA, Jones RN, Doern GV, Sader HS, Messer SA, Houston A, Coffman S and Hollis RJ: Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob Agents Chemother 2000, 44:747-751.
8. Pfaller MA, Messer SA, Hollis RJ, Jones RN, Doern GV, Branddt ME and Hajjeh RA: Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States. Diagn Microbiol Infect Dis 1999, 33:217-222.
9. Pfaller MA, Houston A and Coffmann S: Application of CHRO Magar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata. J Clin Microbiol 1996, 34:58-61.
10. Freydiere AM, Guinet R and Boiron P: Yeast identification in the clinical microbiology laboratory: phenotypical methods. Medical Mycology 2001, 39:9-33.
11. Koehler AP, Chu KC, Houang ETS and Cheng AFB: Simple, reliable, and cost-effective yeast identification scheme for the clinical laboratory. J Clin Microbiol 1999, 37:422-426.
12. Letscher-Bru V, Meyer MH, Galoisy AC, Waller J and Candolfi E: Prospective evaluation of the new chromogenic medium Candida ID, in comparison with Candiselect, for isolation of molds and isolation and presumptive identification of yeast species. J Clin Microbiol 2002, 40:1508-1510.
13. Bauters TG and Nelis HJ: Comparison of chromogenic and fluorogenic membrane filtration methods for detection of four Candida species. J Clin Microbiol 2002, 40:1838-1839.
14. Odds FC and Bernaerts R: CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 1994, 32:1923-1929.
15. Dean AG, Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH, Dicher RC, Sullivan K, Fagan RF and Arner TG: Epi Info, version 6.0: a word processing database, and statistics program epidemiology on microcomputers. Centers for Disease Control and Prevention. Atlanta, Georgia. U.S.A 1994.
16. Beighton D, Ludford R, Clark DT, Brailsford SR, Pankhurst CL, Tinsley GF, Fiske J, Lewis D, Daly B, Khalifa N, Marren V and Lynch E: Use of CHROMagar Candida medium for isolation of yeasts from dental samples. J Clin Microbiol 1995, 33:3025-3027.
17. Tintelnot K, Haase G, Seibold M, Bergmann F, Staemmler M, Franz T and Naumann D: Evaluation of phenotypic markers for selection and identification of Candida dubliniensis. J Clin Microbiol 2000, 38:1599-1608.
18. Willinger B, Hillowoth C, Selitsch B and Manafi M: Performance of Candida ID, a new chromogenic medium for presumptive identification of Candida species, in comparison to CHROMagar Candida. J Clin Microbiol 2001, 39:3793-3795.
19. Jabra-Rizk MA, Brenner TM, Romagnoli M, Baqui AAMA, Merz WG, Falkler WA Jr and Meiller TF: Evaluation of a reformulated CHROMagar Candida. J Clin Microbiol 2001, 39:2015-2016.
20. Yücesoy M, Ergor G and Yulug N: Evaluation of CHROMagar Candida medium for the identification of Candida. Mikrobiyol Bult 2001, 35:549-557.
21. Ainscough S and Kibbler CC: An evaluation of the cost-effectiveness of using CHROMagar for yeast identification in a routine microbiology laboratory. J Med Microbiol 1998, 47:623-628.
22. Bernal S, Martin Mazuelos E, Garcia M, Aller AI, Martinez MA and Gutierrez MJ: Evaluation of CHROMagar Candida medium for the isolation and presumptive identification of species of Candida of clinical importance. Diagn Microbiol Infect Dis 1996, 24:201-204.
23. San-Millan R, Ribacoba L, Ponton J and Quindos G: Evaluation of a commercial medium for identification of Candida species. Eur J Clin Microbiol Infect Dis 1996, 15:153-158.
24. Willinger B and Manafi M: Evaluation of CHROMagar Candida for rapid screening of clinical specimens for Candida species. Mycoses 1999, 42:61-65.
25. Hoppe JE and Frey P: Evaluation of six commercial tests and the germ tube test for presumptive identification of Candida albicans. Eur J Clin Microbiol Infect Dis 1999, 18:188-191.
26. Bouchara JP, Declerck P, Cimon B, Planchenault C, De Gentile L and Chabasse D: Routine use of CHROMagar Candida medium for presumptive identification of Candida yeast species and detection of mixed fungal populations. Clin Microbiol Infect 1996, 2:202-208.
27. Cooke VM, Miles RJ, Price RG, Midgley G, Khamri W and Richardson AC: New chromogenic agar medium for the identification of Candida spp. Appl Environ Microbiol 2002, 68:3622-3627.
28. Freydiére AM: Evaluation of CHROMagar Candida plates. J Clin Microbiol 1996, 34:20-48.